Alchemy Labs Inc. (ALCH : TSX-V)
Common Stock
$0.93
CAD
+0.00 (%)
Last updated: 2026-08-11
Get ALCH alerts:
ALCH
Alchemy Labs Inc.
WealthAwesomePerformance
1 Day
+0.00%
1 Week
-5.10%
1 Month
-
YTD
-12.26%
Key Statistics
Market Cap
$50.73M
52W High
$1.20
52W Low
$0.90
P/E Ratio
-
50 Day MA
$0.99
200 Day MA
$0.99
Beta
-
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 8/11/2026 | $0.92 | $0.93 | $0.90 | $0.93 | $0.93 | 58,207 |
| 8/10/2026 | $0.94 | $0.94 | $0.92 | $0.93 | $0.93 | 25,236 |
| 8/7/2026 | $0.94 | $0.94 | $0.92 | $0.94 | $0.94 | 26,513 |
| 8/6/2026 | $0.96 | $0.96 | $0.93 | $0.95 | $0.95 | 110,303 |
| 8/5/2026 | $0.98 | $0.98 | $0.95 | $0.95 | $0.95 | 50,813 |
| 8/4/2026 | $1.00 | $1.00 | $0.96 | $0.98 | $0.98 | 77,401 |
| 7/31/2026 | $1.00 | $1.00 | $0.97 | $0.98 | $0.98 | 143,102 |
| 7/30/2026 | $0.98 | $1.01 | $0.98 | $1.00 | $1.00 | 27,812 |
| 7/29/2026 | $1.00 | $1.00 | $0.95 | $0.95 | $0.95 | 26,590 |
| 7/28/2026 | $1.00 | $1.00 | $0.96 | $0.98 | $0.98 | 80,465 |
About Alchemy Labs Inc.
Alchemy Labs Inc. operates as a nanotechnology company that engages in researching, developing, and commercializing protective nanocomposite coatings for the automotive and defense markets worldwide. The company develops a range of windshield protection film and paint protection film products for the automotive industry. It also engages in commercializing thermal signature management solutions for the defense industry using its TSM Platform. The company's automotive division offers a range of windshield protection film and paint protection film products under the ExoShield tradename. Its defense unit products are marketed under the Crypsis tradename focusing on commercializing nanoparticle-based thermal signature management solutions for the defense industry. The company's windshield protection products include ExoShield GT3+, a PET based film; ExoShield Ultra for vehicle specific windshields including heavy duty glass; and ExoShield Sprint, a TPU based film designed for weekend drivers and specialty track vehicles. The company's paint protection products include ExoShield Mach 12 and ExoShield Mach S for professional installation. Additionally, the company provides training services and support services. The company's defense solutions division, Crypsis Class, focuses on commercializing nanoparticle-based TSM solutions for use in the defense industry and manufacturing processes and substrates, including textiles, paints and films. Its Crypsis coatings are used across a broad range of applications, such as coated textiles, including ponchos, uniforms, rain gear, winter wear, tents, bags and boots; paints and sprays, including face paints and paint coatings on weapons systems and vehicles; and films and laminates, for use on windows, windshields, sensor housings and vehicle bodies. The company was formerly known as Lawson West Capital Inc. and changed its name to Alchemy Labs Inc. in December 2022. Alchemy Labs Inc. was founded in 2013 and is headquartered in Kitchener, Canada.
Financials
- Revenue (TTM)
- $1.41M
- EBITDA
- $-4.32M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.12
- Book Value
- -0.20
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About ALCH
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| TNX | TenX Protocols Inc. | $46.84 | +66814.29% |
| ARC | Arian Resources Corp. | $0.01 | +100.00% |
| SSX | Sleeping Giant Capital Corp. | $0.10 | +61.54% |
| FEX | Fjordland Exploration Inc | $0.03 | +50.00% |
| BIGT | Big Tree Carbon Inc. | $0.01 | +50.00% |
| ZONE | Zonetail Inc | $0.01 | +50.00% |
| NTX | NeoTerrex Minerals Inc. | $0.12 | +43.75% |
| RTM | RT Minerals Corp | $0.04 | +40.00% |
ALCH.V news timeline
5 articles covering ALCH.V, most recent first
Latest